A NEW PARADIGM IN
Confidence and Resolve – For patients. For healthcare providers. For society. That's the BOLD vision we bring to cardiovascular health around the world. More than four out of five cardiovascular disease (CVD) deaths are due to heart attacks and strokes. One third of these deaths occur prematurely in people under 70 years of age. CVD takes an estimated 17.9 million lives each year, which is approximately 32% of deaths worldwide, making it the leading cause of death globally1.
Amarin is focused on discovering, developing and delivering innovative treatments and new therapeutic approaches that can make a difference in CVD patients' lives. In addition to the ground-breaking science and clinical development, Amarin is highly motivated to improve patient care while creating value for shareholders and society. These are just some of the BOLD ways we are changing the course of CVD.
Learn more about Amarin and our history here►
Get to know Amarin
Who is Amarin? Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease. Amarin is relentless in its pursuit of scientific breakthroughs that can lead to revolutionary solutions, that create a healthier world. Find out more about who we are, what we stand for and how we are making a difference in the lives of patients.
Find out how Amarin has been creating a new paradigm in cardiovascular disease management for over three decades.
Amarin envisions a world where cardiovascular disease is NOT the leading cause of death worldwide.
A rapidly growing international leader, in the fight to address cardiovascular disease.
Amarin focuses on a BOLD vision to stop cardiovascular disease from being a leading cause of death worldwide.
Amarin seeks to collaborate with others to address cardiovascular risk and create value.
WHERE WE ARE
OUR GLOBAL FOOTPRINT
Our work is about making a positive impact on cardiovascular health across the world. Find out where we're located and how we're making a difference globally.
A BOLD INVESTMENT IN CARDIOMETABOLIC HEALTH
Keeping our investors informed about our progress in helping stop cardiovascular disease from being a leading cause of death is important to us. Click here for our investor presentations, events and financial results.
- World Health Organization, World Health Organization, https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1